National Institutes of Health
Seattle Life Science Vacancy Climbs to 22.8% as More Than 500,000 SQFT of New Product Delivers
Two major projects enter Greater Seattle’s lab market in 2025 with moderate preleasing as NIH and venture capital funding both decline year over...
Alexandria Real Estate Slashes Dividend 45% as Life Science Downturn Forces Strategy Shift
The pioneering life science REIT posts its fifth consecutive quarterly loss while accelerating asset sales to shore up balance sheet Alexandria Real Estate...
Seattle Life Sciences Market Faces Headwinds Despite Strong Research Foundation
Vacancy rates climb and leasing activity slows in the Pacific Northwest hub, reflecting broader industry challenges Seattle’s life sciences real estate market is...
Alexandria Real Estate’s Struggles Deepen with Fourth Consecutive Quarterly Loss as Life Science Downturn Continues
Quarterly loss and major asset write-downs signal ongoing challenges for pioneering life science REIT Alexandria Real Estate Equities reported its fourth consecutive quarterly...
Report: Seattle Life Science Market Vacancy Surges to 17% as Funding Recovery Fails to Spur Demand
Market absorption lags despite venture capital rebound to $998M in 2025, up 90.5 percent from prior year Seattle’s life sciences real estate market...
Seattle Life Sciences Market Faces Rising Vacancies as Developers Pump the Brakes
The sector shows mixed signals with surging venture funding, but climbing vacancy rates and stalled construction projects Seattle’s life sciences real estate market...
Life Science Reality Check: Alexandria’s Q1 Performance Reflects Industry Challenges Despite Executive Optimism
Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest...
Report: Seattle’s Life Science Market Continues to Normalize, Finishes 2022 Strong
By Kate Snyder The life science industry continues to normalize after the past couple of years of increased growth. A recent report from...
